{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:34:35Z","timestamp":1791876875620,"version":"4.3.4"},"reference-count":147,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.mce.2008.02.007","type":"journal-article","created":{"date-parts":[[2008,2,20]],"date-time":"2008-02-20T11:59:04Z","timestamp":1203508744000},"page":"169-179","source":"Crossref","is-referenced-by-count":88,"title":["Function and expression of somatostatin receptors of the endocrine pancreas"],"prefix":"10.1016","volume":"286","author":[{"given":"Mathias Z.","family":"Strowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan D.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2008.02.007_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1091-255X(97)80117-5","article-title":"Intraislet somatostatin inhibits insulin (via a subtype-2 somatostatin receptor) but not islet amyloid polypeptide secretion in the isolated perfused human pancreas","volume":"1","author":"Atiya","year":"1997","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.mce.2008.02.007_bib2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/edrv-15-4-516","article-title":"Insulin-dependent diabetes mellitus as an autoimmune disease","volume":"15","author":"Bach","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2008.02.007_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0196-9781(84)90092-5","article-title":"Somatostatin in epithelial cells of intestinal mucosa is present primarily as somatostatin 28","volume":"5","author":"Baskin","year":"1984","journal-title":"Peptides"},{"key":"10.1016\/j.mce.2008.02.007_bib4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1021\/cc990017h","article-title":"A combinatorial approach toward the discovery of non-peptide, subtype-selective somatostatin receptor ligands","volume":"1","author":"Berk","year":"1999","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.mce.2008.02.007_bib5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3109\/00365528708991938","article-title":"Circulating immunoreactive somatostatin in gastrointestinal diseases. Decrease after vagotomy and enhancement in active ulcerative colitis, irritable bowel syndrome, and duodenal ulcer","volume":"22","author":"Binimelis","year":"1987","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.mce.2008.02.007_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/BF00400461","article-title":"Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats","volume":"37","author":"Brand","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2008.02.007_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.179.4068.77","article-title":"Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone","volume":"179","author":"Brazeau","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.mce.2008.02.007_bib8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00006676-200110000-00012","article-title":"Immunoneutralization of somatostatin, insulin, and glucagon causes alterations in islet cell secretion in the isolated perfused human pancreas","volume":"23","author":"Brunicardi","year":"2001","journal-title":"Pancreas"},{"key":"10.1016\/j.mce.2008.02.007_bib9","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1097\/00006676-200311000-00019","article-title":"Activation of somatostatin receptor subtype 2 inhibits insulin secretion in the isolated perfused human pancreas","volume":"27","author":"Brunicardi","year":"2003","journal-title":"Pancreas"},{"key":"10.1016\/j.mce.2008.02.007_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1530\/eje.0.1460707","article-title":"SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile","volume":"146","author":"Bruns","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2008.02.007_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1073\/pnas.70.3.684","article-title":"Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone","volume":"70","author":"Burgus","year":"1973","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2008.02.007_bib12","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1073\/pnas.0510790103","article-title":"The unique cytoarchitecture of human pancreatic islets has implications for islet cell function","volume":"103","author":"Cabrera","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2008.02.007_bib13","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.2337\/diabetes.52.5.1176","article-title":"Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats","volume":"52","author":"Cejvan","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib14","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0026-0495(78)90086-0","article-title":"Twenty-four-hour somatostatin infusions in normals, juvenile diabetics, and maturity-onset diabetics","volume":"27","author":"Christensen","year":"1978","journal-title":"Metabolism"},{"key":"10.1016\/j.mce.2008.02.007_bib15","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/diabetes.39.10.1198","article-title":"Fasting and postprandial concentrations of somatostatin-28 and somatostatin-14 in type II diabetes in men","volume":"39","author":"D\u2019Alessio","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1172\/JCI114246","article-title":"A physiologic role for somatostatin 28 as a regulator of insulin secretion","volume":"84","author":"D\u2019Alessio","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2008.02.007_bib17","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1210\/en.2005-0873","article-title":"Somatostatin inhibits oxidative respiration in pancreatic beta-cells","volume":"147","author":"Daunt","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2008.02.007_bib18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2265.1986.tb03630.x","article-title":"Effects of somatostatin analogue SMS 201-995 in non-insulin-dependent diabetes","volume":"25","author":"Davies","year":"1986","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.mce.2008.02.007_bib19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0960-894X(99)00081-5","article-title":"Potent, orally absorbed glucagon receptor antagonists","volume":"9","author":"de Laszlo","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.mce.2008.02.007_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1677\/erc.1.00962","article-title":"Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas","volume":"13","author":"de Sa","year":"2006","journal-title":"Endocr. Relat Cancer"},{"key":"10.1016\/j.mce.2008.02.007_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0168-8227(00)00203-5","article-title":"Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function","volume":"51","author":"Di Mauro","year":"2001","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.mce.2008.02.007_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00400639","article-title":"Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM","volume":"38","author":"Dinneen","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2008.02.007_bib23","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1523\/JNEUROSCI.16-14-04468.1996","article-title":"Localization of the somatostatin receptor SST2A in rat brain using a specific anti-peptide antibody","volume":"16","author":"Dournaud","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mce.2008.02.007_bib24","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0026-0495(78)90058-6","article-title":"Somatostatin and insulin secretion","volume":"27","author":"Efendic","year":"1978","journal-title":"Metabolism"},{"key":"10.1016\/j.mce.2008.02.007_bib25","first-page":"E40","article-title":"Functional characterization of somatostatin receptors expressed on hamster glucagonoma cells","volume":"268","author":"Fehmann","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2008.02.007_bib26","doi-asserted-by":"crossref","first-page":"E1056","DOI":"10.1152\/ajpendo.00205.2001","article-title":"Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes","volume":"283","author":"Ferone","year":"2002","journal-title":"Am. J. Physiol Endocrinol. Metab."},{"key":"10.1016\/j.mce.2008.02.007_bib27","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1210\/jc.2004-1766","article-title":"Effect of somatostatin on duodenal glucose absorption in man","volume":"90","author":"Fery","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2008.02.007_bib28","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1073\/pnas.0237106100","article-title":"Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice","volume":"100","author":"Gelling","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2008.02.007_bib29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM197409122911102","article-title":"Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications","volume":"291","author":"Gerich","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2008.02.007_bib30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF01234510","article-title":"Clinical evaluation of somatostatin as a potential ajunct to insulin in the management of diabetes mellitus","volume":"13","author":"Gerich","year":"1977","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2008.02.007_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0168-8227(91)90052-F","article-title":"Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin","volume":"14","author":"Giustina","year":"1991","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.mce.2008.02.007_bib32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00006676-199511000-00012","article-title":"Quantitative immunohistochemical changes in the endocrine pancreas of nonobese diabetic (NOD) mice","volume":"11","author":"Gomez Dumm","year":"1995","journal-title":"Pancreas"},{"key":"10.1016\/j.mce.2008.02.007_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00275947","article-title":"Loss of a priming effect of glucose on A and D cell secretion in perfused pancreases from alloxan-diabetic rats: role of insulin and alloxan","volume":"24","author":"Grill","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2008.02.007_bib34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1469-7793.2001.00519.x","article-title":"Somatostatin inhibits exocytosis in rat pancreatic alpha-cells by G(i2)-dependent activation of calcineurin and depriming of secretory granules","volume":"535","author":"Gromada","year":"2001","journal-title":"J. Physiol."},{"key":"10.1016\/j.mce.2008.02.007_bib35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/me.11.5.527","article-title":"Coupling specificity between somatostatin receptor sst2A and G proteins: isolation of the receptor-G protein complex with a receptor antibody","volume":"11","author":"Gu","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2008.02.007_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/jcem-62-1-77","article-title":"Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action","volume":"62","author":"Gutniak","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2008.02.007_bib37","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1530\/acta.0.1210322","article-title":"Impaired somatostatin response to orally administered glucose in type II diabetes entails both somatostatin-28 and -14 and is associated with deranged metabolic control","volume":"121","author":"Gutniak","year":"1989","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.mce.2008.02.007_bib38","first-page":"E269","article-title":"Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action","volume":"250","author":"Hansen","year":"1986","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2008.02.007_bib39","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/diabetes.40.9.1210","article-title":"Morphological analysis of selective destruction of pancreatic beta-cells by cytotoxic T lymphocytes in NOD mice","volume":"40","author":"Hayakawa","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib40","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF00253175","article-title":"Secretion of somatostatin from the normal and diabetic pancreas. Studies in vitro","volume":"19","author":"Hermansen","year":"1980","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2008.02.007_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF00257791","article-title":"Characterisation of the abnormal pancreatic D and A cell function in streptozotocin diabetic dogs: studies with d-glyceraldehyde, dihydroxyacetone, d-mannoheptulose, d-glucose, and l-arginine","volume":"21","author":"Hermansen","year":"1981","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2008.02.007_bib42","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1021\/jm9806289","article-title":"Highly potent cyclic disulfide antagonists of somatostatin","volume":"42","author":"Hocart","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mce.2008.02.007_bib43","doi-asserted-by":"crossref","first-page":"24550","DOI":"10.1074\/jbc.274.35.24550","article-title":"Agonist-dependent up-regulation of human somatostatin receptor type 1 requires molecular signals in the cytoplasmic C-tail","volume":"274","author":"Hukovic","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2008.02.007_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1369\/jhc.6A7024.2006","article-title":"Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases","volume":"55","author":"Iki","year":"2007","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.mce.2008.02.007_bib45","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1172\/JCI108829","article-title":"Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide","volume":"60","author":"Ipp","year":"1977","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2008.02.007_bib46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2362.1997.1740719.x","article-title":"Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours","volume":"27","author":"Jais","year":"1997","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.mce.2008.02.007_bib47","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/diabetes.29.12.960","article-title":"Somatostatin release from the isolated, perfused diabetic rat pancreas: inverse relationship between pancreatic somatostatin and insulin","volume":"29","author":"Kadowaki","year":"1980","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib48","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2265.2001.01396.x","article-title":"The role of chemotherapy in the nonsurgical management of malignant neuroendocrine tumours","volume":"55","author":"Kaltsas","year":"2001","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.mce.2008.02.007_bib49","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1210\/endo-109-2-652","article-title":"Effect of glucose on somatostatin secretion from isolated pancreatic islets of normal and streptozotocin-diabetic rats","volume":"109","author":"Kanatsuka","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2008.02.007_bib50","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1172\/JCI118309","article-title":"Somatostatin coordinately regulates glucagon gene expression and exocytosis in HIT-T15 cells","volume":"96","author":"Kendall","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2008.02.007_bib51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0065-2776(08)60490-3","article-title":"The murine autoimmune diabetes model: NOD and related strains","volume":"51","author":"Kikutani","year":"1992","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.mce.2008.02.007_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1507\/endocrj.48.95","article-title":"Immunohistochemical localization of somatostatin receptor type 2A in rat and human tissues","volume":"48","author":"Kimura","year":"2001","journal-title":"Endocr. J."},{"key":"10.1016\/j.mce.2008.02.007_bib53","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2337\/diabetes.36.5.592","article-title":"Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia","volume":"36","author":"Klaff","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib54","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00006676-199403000-00006","article-title":"Regulatory role of intraislet somatostatin on insulin secretion in the isolated perfused human pancreas","volume":"9","author":"Kleinman","year":"1994","journal-title":"Pancreas"},{"key":"10.1016\/j.mce.2008.02.007_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02825421","article-title":"The influence of somatostatin on glucagon and pancreatic polypeptide secretion in the isolated perfused human pancreas","volume":"18","author":"Kleinman","year":"1995","journal-title":"Int. J. Pancreatol."},{"key":"10.1016\/j.mce.2008.02.007_bib56","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1126\/science.184.4135.482","article-title":"Somatostatin: hypothalamic inhibitor of the endocrine pancreas","volume":"184","author":"Koerker","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.mce.2008.02.007_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diabetes.48.1.77","article-title":"Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis","volume":"48","author":"Kumar","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2337\/diabetes.53.2.410","article-title":"Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db\/db mice","volume":"53","author":"Liang","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01219739","article-title":"Possible mechanism by which somatostatin-induced glucagon suppression improves glucose tolerance during insulinopaenia in man","volume":"17","author":"Liljenquist","year":"1979","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2008.02.007_bib60","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/002215540405200310","article-title":"Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats","volume":"52","author":"Ludvigsen","year":"2004","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.mce.2008.02.007_bib61","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1530\/eje.1.01986","article-title":"Expression of somatostatin receptor subtypes 1-5 in pancreatic islets of normoglycaemic and diabetic NOD mice","volume":"153","author":"Ludvigsen","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2008.02.007_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2006.07.006","article-title":"Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues","volume":"138","author":"Ludvigsen","year":"2007","journal-title":"Regul. Pept."},{"key":"10.1016\/j.mce.2008.02.007_bib63","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1021\/jm0208572","article-title":"Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide","volume":"45","author":"Madsen","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mce.2008.02.007_bib64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1210\/endo-104-1-243","article-title":"Changes in pancreatic somatostatin content in spontaneously diabetic mice, as determined by radioimmunoassay and immunohistochemical methods","volume":"104","author":"Makino","year":"1979","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2008.02.007_bib65","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/291076a0","article-title":"Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion","volume":"291","author":"Mandarino","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.mce.2008.02.007_bib66","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1210\/en.140.8.3790","article-title":"Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic beta-cells","volume":"140","author":"Mitra","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2008.02.007_bib67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/jsre.1995.1136","article-title":"Somatostatin inhibits B-cell secretion via a subtype-2 somatostatin receptor in the isolated perfused human pancreas","volume":"59","author":"Moldovan","year":"1995","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.mce.2008.02.007_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(03)00235-9","article-title":"Somatostatin receptors","volume":"1616","author":"Moller","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mce.2008.02.007_bib69","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2337\/diabetes.53.7.1743","article-title":"A novel variant of ionotropic glutamate receptor regulates somatostatin secretion from delta-cells of islets of Langerhans","volume":"53","author":"Muroyama","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib70","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0021-9258(19)85039-1","article-title":"Suppression of insulin release by galanin and somatostatin is mediated by a G-protein. An effect involving repolarization and reduction in cytoplasmic free Ca2+ concentration","volume":"264","author":"Nilsson","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2008.02.007_bib71","doi-asserted-by":"crossref","first-page":"9397","DOI":"10.1016\/S0021-9258(19)68773-9","article-title":"Synthesis of one form of pancreatic islet somatostatin predominates","volume":"256","author":"Noe","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2008.02.007_bib72","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00000658-200206000-00003","article-title":"Sulfonylurea receptor knockout causes glucose intolerance in mice that is not alleviated by concomitant somatostatin subtype receptor 5 knockout","volume":"235","author":"Norman","year":"2002","journal-title":"Ann. Surg."},{"key":"10.1016\/j.mce.2008.02.007_bib73","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s005950200128","article-title":"Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors","volume":"32","author":"Oda","year":"2002","journal-title":"Surg. Today"},{"key":"10.1016\/j.mce.2008.02.007_bib74","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/jcem-46-3-504","article-title":"Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus","volume":"46","author":"Ohneda","year":"1978","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2008.02.007_bib75","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1073\/pnas.73.4.1338","article-title":"Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes","volume":"73","author":"Orci","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2008.02.007_bib76","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00006676-199005000-00016","article-title":"Abnormal regulation by glucose of somatostatin secretion in the perfused pancreas of NIDDM rats","volume":"5","author":"Ostenson","year":"1990","journal-title":"Pancreas"},{"key":"10.1016\/j.mce.2008.02.007_bib77","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2337\/diabetes.38.6.752","article-title":"Tissue-specific alterations in somatostatin mRNA accumulation in streptozocin-induced diabetes","volume":"38","author":"Papachristou","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib78","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00428-002-0609-x","article-title":"Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis","volume":"440","author":"Papotti","year":"2002","journal-title":"Virchows Arch."},{"key":"10.1016\/j.mce.2008.02.007_bib79","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF03350317","article-title":"Molecular pharmacology of somatostatin receptor subtypes","volume":"20","author":"Patel","year":"1997","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.mce.2008.02.007_bib80","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","article-title":"Somatostatin and its receptor family","volume":"20","author":"Patel","year":"1999","journal-title":"Front Neuroendocrinol."},{"key":"10.1016\/j.mce.2008.02.007_bib81","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0021-9258(19)35416-X","article-title":"Peptides derived from cleavage of prosomatostatin at carboxyl- and amino-terminal segments. Characterization of tissue and secreted forms in the rat","volume":"263","author":"Patel","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2008.02.007_bib82","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1210\/en.135.6.2814","article-title":"Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5)","volume":"135","author":"Patel","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2008.02.007_bib83","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/endo-109-6-1943","article-title":"Multiple forms of immunoreactive somatostatin: comparison of distribution in neural and nonneural tissues and portal plasma of the rat","volume":"109","author":"Patel","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2008.02.007_bib84","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0024-3205(95)02082-T","article-title":"The somatostatin receptor family","volume":"57","author":"Patel","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.mce.2008.02.007_bib85","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1073\/pnas.042705099","article-title":"Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells","volume":"99","author":"Patel","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2008.02.007_bib86","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1073\/pnas.74.5.2140","article-title":"Pancreatic immunoreactive somatostatin release","volume":"74","author":"Patton","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2008.02.007_bib87","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s001250100006","article-title":"Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans","volume":"44","author":"Petersen","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2008.02.007_bib88","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2337\/diabetes.42.2.244","article-title":"Somatostatin inhibits insulin-gene expression through a posttranscriptional mechanism in a hamster islet cell line","volume":"42","author":"Philippe","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib89","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00022744-200006000-00007","article-title":"Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas","volume":"8","author":"Portela-Gomes","year":"2000","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.mce.2008.02.007_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-5793(80)81310-X","article-title":"N-terminally extended somatostatin: the primary structure of somatostatin-28","volume":"109","author":"Pradayrol","year":"1980","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mce.2008.02.007_bib91","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00251826","article-title":"Cellular composition of the human diabetic pancreas","volume":"24","author":"Rahier","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2008.02.007_bib92","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1210\/endo-126-2-1096","article-title":"Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia","volume":"126","author":"Rastogi","year":"1990","journal-title":"Endocrinology"},{"issue":"Suppl. 3","key":"10.1016\/j.mce.2008.02.007_bib93","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000201201","article-title":"Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue","volume":"55","author":"Raulf","year":"1994","journal-title":"Digestion"},{"key":"10.1016\/j.mce.2008.02.007_bib94","doi-asserted-by":"crossref","first-page":"924","DOI":"10.2337\/diabetes.47.6.924","article-title":"Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats","volume":"47","author":"Raz","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib95","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1210\/jcem-64-1-106","article-title":"Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus","volume":"64","author":"Reaven","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2008.02.007_bib96","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1210\/jc.83.10.3746","article-title":"Immunohistochemical localization of somatostatin receptor sst2A in human pancreatic islets","volume":"83","author":"Reubi","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2008.02.007_bib97","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1074\/jbc.275.11.7862","article-title":"Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers","volume":"275","author":"Rocheville","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2008.02.007_bib98","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0928-4257(00)00215-1","article-title":"Identification and characterization of subtype selective somatostatin receptor agonists","volume":"94","author":"Rohrer","year":"2000","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/j.mce.2008.02.007_bib99","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1126\/science.282.5389.737","article-title":"Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry","volume":"282","author":"Rohrer","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.mce.2008.02.007_bib100","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/bbrc.1993.2488","article-title":"Potent inhibitory effects of a type four receptor-selective somatostatin analog on rat insulin release","volume":"197","author":"Rossowski","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2008.02.007_bib101","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/bbrc.1994.2670","article-title":"Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs","volume":"205","author":"Rossowski","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2008.02.007_bib102","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/0196-9781(94)90118-X","article-title":"Characterization of somatostatin receptor subtypes controlling rat gastric acid and pancreatic amylase release","volume":"15","author":"Rossowski","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.mce.2008.02.007_bib103","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.bjp.0702160","article-title":"Examination of somatostatin involvement in the inhibitory action of GIP, GLP-1, amylin and adrenomedullin on gastric acid release using a new SRIF antagonist analogue","volume":"125","author":"Rossowski","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mce.2008.02.007_bib104","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0026-0495(90)90212-U","article-title":"Islet somatostatin\u2014microvascular, paracrine, and pulsatile regulation","volume":"39","author":"Samols","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/j.mce.2008.02.007_bib105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0300-595X(86)80041-X","article-title":"Intra-islet insulin-glucagon-somatostatin relationships","volume":"15","author":"Samols","year":"1986","journal-title":"Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2008.02.007_bib106","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1172\/JCI113593","article-title":"The order of islet microvascular cellular perfusion is B\u2013A\u2013D in the perfused rat pancreas","volume":"82","author":"Samols","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2008.02.007_bib107","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1210\/jc.86.1.140","article-title":"Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas","volume":"86","author":"Saveanu","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2008.02.007_bib108","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/diabetes.28.3.204","article-title":"Effect of fasting on the release of insulin and somatostatin from perifused islets of Langerhans","volume":"28","author":"Schauder","year":"1979","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib109","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0306-4522(96)00388-0","article-title":"Immunohistochemical localization of the somatostatin SST2(A) receptor in the rat brain and spinal cord","volume":"76","author":"Schindler","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.mce.2008.02.007_bib110","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00001756-199802160-00027","article-title":"Localization of the somatostatin sst2(a) receptor in human cerebral cortex, hippocampus and cerebellum","volume":"9","author":"Schindler","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.mce.2008.02.007_bib111","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1046\/j.1460-9568.1998.00386.x","article-title":"Immunocytochemical localization of somatostatin receptor sst2A in the rat spinal cord and dorsal root ganglia","volume":"10","author":"Schulz","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.mce.2008.02.007_bib112","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1464-5491.1989.tb01153.x","article-title":"Basal and tolbutamide-induced plasma somatostatin in healthy subjects and in patients with diabetes and impaired glucose tolerance","volume":"6","author":"Segers","year":"1989","journal-title":"Diabet. Med."},{"key":"10.1016\/j.mce.2008.02.007_bib113","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1074\/jbc.275.13.9270","article-title":"Sur1 knockout mice. A model for K(ATP) channel-independent regulation of insulin secretion","volume":"275","author":"Seghers","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2008.02.007_bib114","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0025-6196(12)62083-7","article-title":"Functioning insulinoma\u2014incidence, recurrence, and long-term survival of patients: a 60-year study","volume":"66","author":"Service","year":"1991","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.mce.2008.02.007_bib115","first-page":"E283","article-title":"Impact of lack of suppression of glucagon on glucose tolerance in humans","volume":"277","author":"Shah","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2008.02.007_bib116","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1210\/jc.85.11.4053","article-title":"Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus","volume":"85","author":"Shah","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2008.02.007_bib117","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1172\/JCI119225","article-title":"Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation","volume":"99","author":"Shimon","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2008.02.007_bib118","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1172\/JCI119779","article-title":"Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors","volume":"100","author":"Shimon","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2008.02.007_bib119","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s002109900141","article-title":"Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies","volume":"360","author":"Siehler","year":"1999","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.mce.2008.02.007_bib120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1210\/jc.2006-1578","article-title":"Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets","volume":"92","author":"Singh","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2008.02.007_bib121","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1210\/en.2006-1659","article-title":"Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition","volume":"148","author":"Singh","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2008.02.007_bib122","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/acta.0.1090517","article-title":"Increased peripheral venous somatostatin concentration and decreased glucagon response to arginine in patients with insulin dependent diabetes mellitus without residual B-cell function. Increased plasma SRIF in IDDM","volume":"109","author":"Skare","year":"1985","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.mce.2008.02.007_bib123","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2337\/diabetes.32.4.293","article-title":"A quantitative immunofluorescent study of the endocrine cell populations in the developing human pancreas","volume":"32","author":"Stefan","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib124","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1210\/en.141.1.111","article-title":"Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice","volume":"141","author":"Strowski","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2008.02.007_bib125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1210\/me.2001-0035","article-title":"Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis","volume":"17","author":"Strowski","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2008.02.007_bib126","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1210\/en.2006-0274","article-title":"Antidiabetic activity of a highly potent and selective non-peptide somatostatin receptor subtype-2 agonist","volume":"147","author":"Strowski","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2008.02.007_bib127","first-page":"E598","article-title":"Evidence of a paracrine role for pancreatic somatostatin in vivo","volume":"245","author":"Taborsky","year":"1983","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2008.02.007_bib128","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1172\/JCI111194","article-title":"Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog","volume":"73","author":"Taborsky","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2008.02.007_bib129","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2337\/diabetes.50.8.1891","article-title":"Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes","volume":"50","author":"Takano","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1507\/endocrj.52.605","article-title":"Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study","volume":"52","author":"Taniyama","year":"2005","journal-title":"Endocr. J."},{"key":"10.1016\/j.mce.2008.02.007_bib131","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1097\/00006676-200304000-00025","article-title":"Pancreatic somatostatin inhibits insulin secretion via SSTR-5 in the isolated perfused mouse pancreas model","volume":"26","author":"Tirone","year":"2003","journal-title":"Pancreas"},{"key":"10.1016\/j.mce.2008.02.007_bib132","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1210\/en.143.4.1218","article-title":"Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment","volume":"143","author":"Tulipano","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2008.02.007_bib133","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(75)91985-6","article-title":"Letter: glucagon in pathogenesis of diabetes","volume":"1","author":"Unger","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2008.02.007_bib134","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/diab.25.2.136","article-title":"The Banting Memorial Lecture 1975. Diabetes and the alpha cell","volume":"25","author":"Unger","year":"1976","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(75)92375-2","article-title":"The essential role of glucagon in the pathogenesis of diabetes mellitus","volume":"1","author":"Unger","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2008.02.007_bib136","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/diabetes.26.3.241","article-title":"Possible roles of the pancreatic D-cell in the normal and diabetic states","volume":"26","author":"Unger","year":"1977","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2008.02.007_bib137","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1056-8727(00)00063-5","article-title":"Octreotide administration in diabetic rats: effects on renal function and morphology","volume":"14","author":"Usenmez","year":"2000","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.mce.2008.02.007_bib138","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/jc.2003-031052","article-title":"A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients","volume":"89","author":"van der Hoek","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2008.02.007_bib139","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.surg.2004.05.042","article-title":"Double-gene ablation of SSTR1 and SSTR5 results in hyperinsulinemia and improved glucose tolerance in mice","volume":"136","author":"Wang","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.mce.2008.02.007_bib140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jss.2005.05.024","article-title":"The effect of global SSTR5 gene ablation on the endocrine pancreas and glucose regulation in aging mice","volume":"129","author":"Wang","year":"2005","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.mce.2008.02.007_bib141","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2005.11.002","article-title":"Alterations in glucose homeostasis in SSTR1 gene-ablated mice","volume":"247","author":"Wang","year":"2006","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.mce.2008.02.007_bib142","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1210\/en.2002-220219","article-title":"SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone\/insulin-like growth factor-I axis in rats, primates, and dogs","volume":"143","author":"Weckbecker","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2008.02.007_bib143","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.95.18.10836","article-title":"Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2","volume":"95","author":"Yang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2008.02.007_bib144","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0006-2952(99)00010-6","article-title":"Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5","volume":"57","author":"Zambre","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mce.2008.02.007_bib145","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1210\/jc.86.5.2161","article-title":"Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt","volume":"86","author":"Zatelli","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2008.02.007_bib146","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0006-291X(02)02307-0","article-title":"Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line","volume":"297","author":"Zatelli","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2008.02.007_bib147","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1210\/me.11.11.1709","article-title":"Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons","volume":"11","author":"Zheng","year":"1997","journal-title":"Mol. Endocrinol."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720708000683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720708000683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T08:53:25Z","timestamp":1630745605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720708000683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":147,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0303720708000683"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2008.02.007","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}